{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigij6pcj3t3jpykgb6ovvpncyoitrbi5ykzbf6pa3yrjdbbswbeya",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mpm6mrxasrm2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreia6ojpb24wngwaghybhlowpxhm5hmpsqf56ijk6vs5og3bbg2cl7i"
    },
    "mimeType": "image/jpeg",
    "size": 159021
  },
  "path": "/news/2026-07-car-cell-therapy-key-mutation.html",
  "publishedAt": "2026-07-01T14:00:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to new research led by UCL and University of Oxford researchers.",
  "title": "CAR T cell therapy targets key mutation driving rare blood cancers"
}